Nobel Laureates to teach Australian scientists
Australia | News | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2012
Singapore: The best of the young Australian scientists will get a chance of a lifetime to be mentored by Nobel Prize win...Read more
Biota Pharma to axe two-thirds of its workforce
Australia | News | By BioSpectrum Bureau | 0 Comment | 03 Jun, 2014
Singapore: Biota pharma has adopted a plan to restructure its operations, aiming to re-align and cut down its work force...Read more
Former Pfizer executive joins Agenix
Australia | News | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2012
Singapore: Australian drug development company Agenix has appointed international biomedical business development expert...Read more
2014's Top 20 Companies: RANK 2
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 14 Jul, 2014
Starting the year on a positive note, Australia's CSL with presence in over 27 countries, charted strong performance a...Read more
Bionomics reveals data on Alzheimer's drug candidate
Australia | News | By BioSpectrum Bureau | 0 Comment | 04 Feb, 2013
Singapore: Australian company Bionomics has made public new data on BNC375, its drug candidate with potential for the tr...Read more
Allied raises $1.7 mn to invest in CardioCel patch
Australia | News | By BioSpectrum Bureau | 0 Comment | 17 Dec, 2012
Singapore: Australia's Allied Healthcare Group has successfully completed an oversubscribed strategic placement which ra...Read more
Genzyme multiple sclerosis drug gets TGA nod
Australia | News | By BioSpectrum Bureau | 0 Comment | 22 Nov, 2012
Singapore: Australian therapeutic goods administration (TGA) has approved Aubagio (teriflunomide) 14 mg as a new once-da...Read more
Living Cell Technologies appoints Andrea Grant to board
Australia | News | By BioSpectrum Bureau | 0 Comment | 16 Nov, 2012
Singapore: ASX-listed Living Cell Technologies has appointed Dr Andrea Grant to the board as managing director. Mr Roy A...Read more
DRL launches Alchemia thrombosis generic in India
Australia | News | By BioSpectrum Bureau | 0 Comment | 04 Apr, 2013
Singapore: Alchemia's commercialization partner Dr Reddy's Laboratories has launched Alchemia's FDA approved generic an...Read more
Phosphagenics licenses antibody product to Agila
Australia | News | By BioSpectrum Bureau | 0 Comment | 30 Oct, 2012
Bangalore: Australian drug delivery technology company Phosphagenics has licensed an injectable antibiotic product, har...Read more
Bionomics: Our kidney cancer trial shows clinical benefit
Australia | News | By BioSpectrum Bureau | 0 Comment | 06 Jun, 2013
Singapore: Bionomics presented an update on its renal cancer candidate's (BNC105) clinical trial program at the annual A...Read more
Osprey to capitalize on CINCOR system
Australia | Influencers | By BioSpectrum Bureau | 0 Comment | 04 Jul, 2012
Contrast induced nephropathy (CIN) is a form of kidney damage caused by the toxic effects of dyes (contrast) used by car...Read more
Prana provides updates on clinical trials of PBT2
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Aug, 2012
Singapore: Prana Biotechnology, listed with the ASX, has reported progress in the phase II clinical trials with its lead...Read more
Australian scientists find gene affecting male fertility
Australia | News | By BioSpectrum Bureau | 0 Comment | 19 Aug, 2013
Singapore: A team of cancer scientists from The University of Western Australia (UWA) have found that the gene known to ...Read more
Changes in US patent law to impact global biotech
Australia | News | By BioSpectrum Bureau | 0 Comment | 07 Oct, 2012
Singapore: The US has been making several modifications to its patent laws lately and this is impacting the global biote...Read more
iSonea asthma monitor AirSonea gets CE mark
Australia | News | By BioSpectrum Bureau | 0 Comment | 05 Sep, 2013
Singapore: Australia-based medical technology company iSonea has completed testing and technical documentation for the A...Read more
Bionomics gives update about BNC105 trials
Australia | News | By BioSpectrum Bureau | 0 Comment | 09 Jan, 2013
Singapore: Australia-based Bionomics' CEO, Dr Deborah Rathjen, has provided an update about the company at the Biotech...Read more
Michael Culme-Seymour is Marken's new APAC VP
Australia | Influencers | By BioSpectrum Bureau | 2 Comment | 04 Oct, 2013
‎Singapore: Supply chain firm, Marken has appointed Mr Michael Culme-Seymour as VP, Asia Pacific, effective Octobe...Read more